Risk factors and foetal growth restriction associated with expectant treatment of early-onset preeclampsia

References

• Brown MA, Magee LA, Kenny LC, International Society for the Study of Hypertension in Pregnancy (ISSHP), et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
   PubMed Web of Science ®Google Scholar
• L’Omelette AD, Dawonauth L, Rademacher L, et al. New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-type. J Reprod Immunol. 2018;125:64–71.
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145(S1):1–33.
   PubMed Web of Science ®Google Scholar
• Durst JK, Tuuli MG, Stout MJ, et al. Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol. 2016;214(5):651.e1–5.
   PubMed Web of Science ®Google Scholar
• Kucukgoz Gulec U, Ozgunen FT, Buyukkurt S, et al. Comparison of clinical and laboratory findings in early- and late-onset preeclampsia. J Matern Fetal Med. 2013;26(12):1228–1233.
   Google Scholar
• Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71–78.
   PubMed Web of Science ®Google Scholar
• Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hypertens Rep. 2015;17(11):83.
   PubMed Web of Science ®Google Scholar
• Brosens I, Pijnenborg R, Vercruysse L, et al. The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
   PubMed Web of Science ®Google Scholar
• Mclaughlin K, Zhang J, Lye SJ, et al. Phenotypes of pregnant women who subsequently develop hypertension in pregnancy. J Am Heart Assoc. 2018;7:e009595.
   PubMed Web of Science ®Google Scholar
• Monteith C, Egan K, O’Connor H, et al. Early onset preeclampsia is associated with an elevated mean platelet volume (MPV) and a greater rise in MPV from time of booking compared with pregnant controls: results of the CAPE study. J Perinat Med. 2018;46(9):1010–1015.
   PubMed Web of Science ®Google Scholar
• Omer W, Yael Y, Tal W, et al. Preeclampsia: risk factors and neonatal outcomes associated with early- versus late-onset disease. J Matern Fetal Neonatal Med. 2018;9:780–784.
   Google Scholar
• Madazli R, Yuksel MA, Imamoglu M, et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch Gynecol Obstet. 2014;290(1):53–57.
   PubMed Web of Science ®Google Scholar
• Stergiotou I, Crispi F, Valenzuela-Alcaraz B, et al. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol. 2013;209(6):558.e1–14.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Melchiorre K, Khalil A, et al. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2014;44(3):293–298.
   PubMed Web of Science ®Google Scholar
• Churchill D, Duley L, Thornton JG, et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks’ gestation. Cochrane Database Syst Rev. 2013;7:CD003106.
   PubMed Web of Science ®Google Scholar
• Sato Y, Moriuchi K, Sakae-Matsumoto C, et al. Factors contributing to favourable neonatal outcomes in early-onset severe preeclampsia. J Obstet Gynaecol. 2021;41(1):60–65.
   PubMedGoogle Scholar
• ACOG. Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Wallace K, Harris S, Addison A, et al. HELLP syndrome: pathophysiology and current therapies. Curr Pharm Biotechnol. 2018;19(10):816–826.
   PubMed Web of Science ®Google Scholar
• ACOG. Practice bulletin no. 204: fetal growth restriction. Obstet Gynecol. 2019;133:e97–e109.
   PubMedGoogle Scholar
• Bokslag A, van Weissenbruch M, Mol BW, et al. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50.
   PubMed Web of Science ®Google Scholar
• van Esch JJA, van Heijst AF, de Haan AFJ, et al. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Matern Fetal Neonatal Med. 2017;30(23):2789–2794.
   PubMed Web of Science ®Google Scholar
• Büyükeren M, Çelik HT, Örgül G, et al. Neonatal outcomes of early- and late-onset preeclampsia. Turk J Pediatr. 2020;62(5):812–819.
   PubMed Web of Science ®Google Scholar
• Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.
   PubMed Web of Science ®Google Scholar
• Jardim LL, Rios DR, Perucci LO, et al. Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia? Clin Chim Acta. 2015;447:34–38.
   PubMed Web of Science ®Google Scholar
• Pagani F, Cantaluppi V. Renal injury during preclampsia: role of extracellular vesicles. Nephron 2019;143(3):197–201.
   PubMed Web of Science ®Google Scholar
• Morikawa M, Mayama M, Saito Y, et al. Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria. Pregnancy Hypertens. 2020;21:111–117.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim YN, Jung EJ, et al. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia? Obstet Gynecol Sci. 2017;60(3):260–265.
   PubMedGoogle Scholar
• Sarno L, Maruotti GM, Saccone G, et al. Pregnancy outcome in proteinuria-onset and hypertension-onset preeclampsia. Hypertens Pregnancy. 2015;34(3):284–290.
   PubMed Web of Science ®Google Scholar
• Özkara A, Kaya AE, Başbuğ A, et al. Proteinuria in preeclampsia: is it important? Ginekol Pol. 2018;89(5):256–261.
   PubMed Web of Science ®Google Scholar
• Dong X, Gou WL, Li CF, et al. Proteinuria in preeclampsia: not essential to diagnosis but related to disease severity and fetal outcomes. Pregnancy Hypertens. 2017;8:60–64.
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Coomarasamy A, O’Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10.
   PubMed Web of Science ®Google Scholar
• Deshpande SS, Balasinor NH. Placental defects: an epigenetic perspective. Reprod Sci. 2018;25(8):1143–1160.
   PubMed Web of Science ®Google Scholar
• Salomon LJ, Malan V. Managing and identifying the causes of IUGR. J Gynecol Obstet Biol Reprod. 2013;42(8):929–940.
   PubMedGoogle Scholar
• Groom KM, David AL. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S829–S840.
   PubMed Web of Science ®Google Scholar
• Hung TH, Hsieh TT, Chen SF. Risk of abnormal fetal growth in women with early- and late-onset preeclampsia. Pregnancy Hypertens. 2018;12:201–206.
   PubMed Web of Science ®Google Scholar